Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis-Reference-Cited by-同舟云学术

Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis

Published:2012-02-02 Issue:4 Volume:34 Page:548-560
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Girolomoni Giampiero,Altomare Gianfranco,Ayala Fabio,Berardesca Enzo,Calzavara-Pinton Piergiacomo,Chimenti Sergio,Peserico Andrea,Puglisi Guerra Antonio,Vena Gino Antonio

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.3109/08923973.2011.653646

Reference133 articles.

1. Guidelines of care for the management of psoriasis and psoriatic arthritis

2. Guidelines of care for the management of psoriasis and psoriatic arthritis

3. Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions

4. Psoriasis and Atherothrombotic Diseases: Disease-Specific and Non–Disease-Specific Risk Factors

5. Current severe psoriasis and the Rule of Tens

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of infections in psoriatic arthritis or axial spondyloarthritis patients treated with targeted therapies: A meta-analysis of randomized controlled trials;Joint Bone Spine;2024-05

2. Nailfold Videocapillaroscopy in Patients with Rheumatoid Arthritis and Psoriatic Arthropathy on ANTI-TNF-ALPHA Therapy;Diagnostics;2023-06-15

3. Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo‐Controlled DISCOVER‐1 Study;ACR Open Rheumatology;2023-02-10

4. Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis;The Journal of Rheumatology;2023-01-15

5. A double-edged sword: ROS related therapies in the treatment of psoriasis;Asian Journal of Pharmaceutical Sciences;2022-11